drugset / Trial / NCT00105482

Targeted Interventions for Weight-Concerned Smokers

NCT00105482

RandomizedParallel-groupTriple-blindTreatment

Summary

Weight gain after quitting smoking is an important barrier to treatment for many smokers. This study will test a drug called naltrexone with weight-concerned smokers to investigate whether or not this drug both improves smoking cessation quit rates and minimizes post quit weight gain.

Timeline

Start
2005-01
Primary completion
2009-04
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 25 mg Oral
Background Nicotine Unknown 21 mg Other

Indications